Word

Status

Pending

Status Code

630

Status Date

Thursday, July 11, 2024

Serial Number

79399473

Mark Type

2

Filing Date

Thursday, May 2, 2024

Trademark Owner History

Bicycletx Limited

Classifications

5 Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical products and preparations for use in relation to oncology; pharmaceutical products and preparations for use in relation to ophthalmology; pharmaceutical products and preparations for use in relation to neurology; anti-infective pharmaceutical products and preparations; pharmaceutical products and preparations for the treatment and/or prevention of respiratory disease; pharmaceutical products and preparations for the treatment and/or prevention of cardiovascular disease; pharmaceutical products and preparations for the treatment and/or prevention of metabolic disease; pharmaceutical products and preparations for the treatment and/or prevention of viral infections; pharmaceutical products and preparations for use in diagnostics and imaging; pharmaceutical products and preparations for the treatment and/or prevention of renal disease; pharmaceutical products and preparations for the treatment and/or prevention of gastrointestinal disease; pharmaceutical products and preparations for the treatment and/or prevention of muscular skeletal disease.

44 Medical services; medical testing; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid.

42 Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical research and development services; medical research and development services; pharmaceutical testing and clinical trials; clinical trials; research and development in the field of oncology; research and development in the field of ophthalmology; research and development in the field of neurology; research and development in the field of anti-infective pharmaceuticals; research and development in the field of respiratory disease; research and development in the field of cardiovascular disease; research and development in the field of metabolic disease; research and development in the field of antiviral drugs; research and development in the field of diagnostics and imaging; research and development in the field of renal disease; research and development in the field of gastrointestinal disease; research and development in the field of muscular skeletal disease; information consultancy and advisory services relating to the aforesaid.

Trademark Events

Jul 11, 2024

Sn Assigned For Sect 66a Appl From Ib

Jul 12, 2024

Application Filing Receipt Mailed

Jul 12, 2024

New Application Office Supplied Data Entered